Catalyst

“As a patient myself...” - our CEO Rich Daly opens up about why Catalyst's dedication to patient care runs so deep. From his first introduction to our company 10 years ago to today, one thing hasn't changed: our promise to put patients first. In this powerful episode of #CatalystConvos, hear how personal experience shapes our company's heartfelt commitment to supporting every patient's journey: catalystpharma.com/catalyst-convos

Catalyst is back at @AANmember's #AANAM! Come visit us at booth #4811 to learn more about Catalyst's contribution to the rare neuromuscular disease community: catalystpharma.com.

Want to learn more about Duchenne muscular dystrophy (#DMD)? DMD is the most common form of muscular dystrophy and affects about 1 in 4,000 boys. It causes progressive muscle weakness beginning in early childhood. Learn more: catalystpharma.com/dmd

Coordinated care can sometimes make the difference in a patient's life. Tescha, a patient living with Lambert-Eaton myasthenic syndrome (LEMS), emphasizes how important it is for her doctors to communicate across specialties. Managing LEMS can involve multiple providers, and coordinated care makes a big difference in her journey. Learn more: lemsaware.com/finding-a-spec…

March 30 was LEMS Awareness Day, a day to spotlight Lambert‑Eaton myasthenic syndrome (LEMS). LEMS is a rare neuromuscular disease that can have a profound effect on a person’s mobility and quality of life. To show their support, members of our Catalyst team joined the @LEMSFamily's call to wear yellow and help bring greater awareness to the LEMS community. Learn more about them and the role they play in advancing LEMS awareness: lemsfamily.org. #LEMS #raredisease

Are you at the Texas Lung Conference in Austin, Texas? Visit the Catalyst table to learn about Lambert-Eaton myasthenic syndrome (#LEMS), a rare neuromuscular disorder, and its link to co-occurring cancers, including small cell lung cancer (SCLC): cancerassociatedlems.com. #TexasLung26

On World Health Day, remember: your health matters. Trust your instincts, ask questions, and reach out to your doctor when something feels off. Your voice in your care matters. Track your symptoms and bring questions to your appointment to make the most of your time with your healthcare provider. Today and every day, let’s make our health a priority: catalystpharma.com. #WorldHealthDay

Our Catalyst team attended the Muscular Dystrophy Association (@MDAorg) conference where cross‑functional teams came together to raise awareness of Duchenne muscular dystrophy (#DMD) and advance conversations around community support and treatment opportunities. #MDAconference

Today marks the first-ever Oncology Pharmacist Day, an observance created by @HOPArx to recognize the role oncology pharmacists play in cancer care. This day highlights the expertise behind ensuring cancer treatments are safe, effective, personalized, and accessible. Oncology pharmacists are essential members of the care team—educating patients and caregivers, supporting medication access, and safeguarding the appropriate use of complex therapies. Their role is especially critical for individuals facing rare and cancer-associated conditions, including cancer‑associated Lambert-Eaton myasthenic syndrome. Learn more about #OncologyPharmacistDay and how you can take part in recognizing the impact these professionals make every day: hoparx.org/latest-news/on….

Suddenly, traveling just got a bit different. Things like luggage, a backup plan, and priority boarding are now on your mind like never before - that's how Jamie's life changed after her diagnosis of Lambert-Eaton myasthenic syndrome (LEMS). In our LEMS Aware blog post, Jamie gave helpful tips on how your next trip can be easier with a bit of planning if you have #LEMS. Read more here: lemsaware.com/blog/tips-for-….

Today, we recognize LEMS Awareness Day! Lambert‑Eaton myasthenic syndrome (LEMS) is a rare neuromuscular disease, and today is all about learning, sharing, and spreading awareness. March 30th commemorates the important research of Dr. Edward Lambert and Dr. Lee Eaton, whose discoveries brought LEMS into focus and transformed how the condition is understood. Catalyst Pharmaceuticals supports the 3rd annual #LEMSAwarenessDay, which was established in 2024 by the Lambert-Eaton LEMS Family Association. This day is dedicated to spreading awareness, improving diagnoses, and uniting the LEMS community. Get involved and discover more about LEMS: lemsfamily.org & lemsaware.com.

In recognition of Lambert-Eaton myasthenic syndrome (LEMS) Awareness Day, we’re shining a light on some of our incredible ambassadors. Whether they are caregivers or individuals living with LEMS, each person brings a unique story and perspective to our community. Living with LEMS is not a one‑size‑fits‑all experience. This rare neuromuscular disease can look different for everyone, and our ambassadors reflect that diversity. Through their journeys, they show the many ways LEMS can impact daily life, while also highlighting the strength, connection, and support found within the LEMS community: lemsaware.com/blog/

Attending Sunshine Eye & Retina-Healio this week, healthcare providers? With oculobulbar involvement occurring in roughly 50% of affected patients, neuro-ophthalmologists may play a pivotal role in diagnosing and treating Lambert-Eaton myasthenic syndrome (LEMS). Learn how to recognize the signs by visiting Catalyst at booth #59: lemsawarehcp.com/recognizing-le…

Test your knowledge of Lambert‑Eaton myasthenic syndrome (LEMS) and help raise awareness. How many of the five facts did you recognize? While living with LEMS can come with challenges, support is always within reach. These amazing organizations and resources are ready to help: 🔹 The Lambert-Eaton LEMS Family Association (lemsfamily.org) – Supporting patients and families through education, advocacy, and community. 🔹 National Organization for @RareDiseases (rarediseases.org) – Empowering rare disease patients with resources and advocacy. 🔹 LEMSaware.com – Your go-to hub for information, resources, and patient stories. Let's raise awareness and build a stronger LEMS community!

To celebrate Women’s History Month, we're thrilled to celebrate some of the extraordinary women of Catalyst. Your expertise, vision, and dedication are at the heart of who we are, and we are proud to be an organization shaped by your leadership every day. #WomensHistoryMonth

Healthcare providers, we're at @NANOSTweets - North American Neuro-Ophthalmology Society! Do you know how to spot the ophthalmic signs of Lambert-Eaton myasthenic syndrome (LEMS)? Visit the Catalyst table to hear more about symptoms such as ptosis, diplopia, and an FDA-approved treatment for LEMS: lemsawarehcp.com/recognizing-le…

At our inaugural Catalyst Advocacy Scholars Summit (CASS), we turned the spotlight on our scholars at the start of the week, asking what they hoped to discover and what drew them to patient advocacy. Their curiosity, insight, and passion for patient communities were clear from day one. Watch to hear directly from these future healthcare providers and patient advocates as they share their early reflections: ir.catalystpharma.com/news/news-deta…. #CASS2026

When a loved one is diagnosed with a rare disease, caregiving often becomes an integral part of who you are. Bill, a father and caregiver to a son with Duchenne muscular dystrophy (DMD), shares his personal journey of navigating the emotional challenges of this role. Listen to his story on #CatalystConvos: catalystpharma.com/catalyst-convos

Our team attended the 48th Annual Carrell Krusen Neuromuscular Symposium, an immersive clinical education experience designed for multidisciplinary care teams supporting patients with rare and complex neuromuscular conditions. The symposium focuses on disorders such as hereditary muscular dystrophies, motor neuron diseases, neuroimmunologic neuropathies, and rare diseases affecting muscle and nerve, like Lambert-Eaton myasthenic syndrome (LEMS) and Duchenne muscular dystrophy (DMD).

Our President & CEO, Rich Daly, along with other members of our management team, recently participated in the @Barclays 28th Annual Global Healthcare Conference, where we highlighted our exceptional 2025 performance, shared more details around our 2026 guidance, and outlined the growth strategy for our promoted products. Learn more about Catalyst’s 2026 Full Year Financial Guidance: ir.catalystpharma.com/news/news-deta…